N Scott Fine - Net Worth and Insider Trading
N Scott Fine Net Worth
The estimated net worth of N Scott Fine is at least $319,081 dollars as of 2024-11-13. N Scott Fine is the CEO of Cyclo Therapeutics Inc and owns about 444,402 shares of Cyclo Therapeutics Inc (CYTH) stock worth over $319,081. Details can be seen in N Scott Fine's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that N Scott Fine has not made any transactions after 2023-04-20 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of N Scott Fine
N Scott Fine Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, N Scott Fine owns 2 companies in total, including Cyclo Therapeutics Inc (CYTH) , and Forward Industries Inc (FORD) .
Click here to see the complete history of N Scott Fine’s form 4 insider trades.
Insider Ownership Summary of N Scott Fine
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CYTH | Cyclo Therapeutics Inc | 2023-04-20 | director |
| FORD | Forward Industries Inc | 2015-02-23 | director |
N Scott Fine Latest Holdings Summary
N Scott Fine currently owns a total of 1 stock. N Scott Fine owns 444,402 shares of Cyclo Therapeutics Inc (CYTH) as of April 20, 2023, with a value of $319,081.
Latest Holdings of N Scott Fine
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CYTH | Cyclo Therapeutics Inc | 2023-04-20 | 444,402 | 0.72 | 319,081 |
Holding Weightings of N Scott Fine
N Scott Fine Form 4 Trading Tracker
According to the SEC Form 4 filings, N Scott Fine has made a total of 7 transactions in Cyclo Therapeutics Inc (CYTH) over the past 5 years, including 7 buys and 0 sells. The most-recent trade in Cyclo Therapeutics Inc is the acquisition of 299,402 shares on April 20, 2023, which cost N Scott Fine around $212,575.
Insider Trading History of N Scott Fine
- 1
N Scott Fine Trading Performance
GuruFocus tracks the stock performance after each of N Scott Fine's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by N Scott Fine is -6.3%. GuruFocus also compares N Scott Fine's trading performance to market benchmark return within the same time period. The performance of stocks bought by N Scott Fine within 3 months outperforms 2 times out of 9 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how N Scott Fine's insider trading performs compared to the benchmark.
Performance of N Scott Fine
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 0.46 | | | | | |
| Relative Return to S&P 500(%) | 0.66 | | | | | |
N Scott Fine Ownership Network
Ownership Network List of N Scott Fine
Ownership Network Relation of N Scott Fine
N Scott Fine Owned Company Details
What does Cyclo Therapeutics Inc do?
Who are the key executives at Cyclo Therapeutics Inc?
N Scott Fine is the director of Cyclo Therapeutics Inc. Other key executives at Cyclo Therapeutics Inc include 10 percent owner Rafael Holdings, Inc. , director & Chief Executive Officer Jeffrey Tate , and SVP for Medical Affairs Sharon Hemond Hrynkow .
Cyclo Therapeutics Inc (CYTH) Insider Trades Summary
Over the past 18 months, N Scott Fine made no insider transaction in Cyclo Therapeutics Inc (CYTH). Other recent insider transactions involving Cyclo Therapeutics Inc (CYTH) include a net purchase of 4,000,000 shares made by Rafael Holdings, Inc. ,
In summary, during the past 3 months, insiders sold 0 shares of Cyclo Therapeutics Inc (CYTH) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Cyclo Therapeutics Inc (CYTH) were sold and 4,000,000 shares were bought by its insiders, resulting in a net purchase of 4,000,000 shares.
Cyclo Therapeutics Inc (CYTH)'s detailed insider trading history can be found in Insider Trading Tracker table.
Cyclo Therapeutics Inc Insider Transactions
N Scott Fine Mailing Address
Above is the net worth, insider trading, and ownership report for N Scott Fine. You might contact N Scott Fine via mailing address: 600 3rd Ave, New York Ny 10016.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
